Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 7, 2014, Pages 2008-2010

  Strunk, Ann Kathrin ^a   Schmidt, Julius J ^a   Baroke, Eva ^a   Bode Böger, Stefanie M ^b   Martens Lobenhoffer, Jens ^b   Welte, Tobias ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

CMS; Colistin methanesulfonate; PK; Renal replacement therapy

Indexed keywords

COLISTIMETHATE; COLISTIN; ANTIINFECTIVE AGENT;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; ASPERGILLOSIS; BLOOD SAMPLING; CASE REPORT; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; DISEASE COURSE; DRUG BLOOD LEVEL; ENDOTRACHEAL INTUBATION; EXTENDED DAILY DIALYSIS; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LETTER; LOADING DRUG DOSE; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NONINVASIVE VENTILATION; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; ACUTE KIDNEY INJURY; CHEMISTRY; PLASMA; PROCEDURES; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; ADULT; ANTI-BACTERIAL AGENTS; COLISTIN; HUMANS; PLASMA; RENAL DIALYSIS;

EID: 84902517770     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku075     Document Type: Letter

References (10)

1. Bergen PJ, Li J, Nation RL. Dosing of colistin-back to basic PK/PD. Curr Opin Pharmacol 2011; 11: 464-9.
2. Couet W, Gregoire N, Gobin P et al. Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers. Clin Pharmacol Ther 2011; 89: 875-9.
3. Bergen PJ, Landersdorfer CB, Zhang J et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Diagn Microbiol Infect Dis 2012; 74: 213-23.
4. Curitis JR, Eastwood JB. Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis. Br Med J 1968; 1: 484-5.
5. Gobin P, Lemaitre F, Marchand S et al. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatographytandem mass spectrometry. Antimicrob Agents Chemother 2010; 54: 1941-8.
6. Bode-Boger SM, Schopp B, Troger U et al. Intravenous colistin in a patient with serious burns and borderline syndrome: the benefits of therapeutic drug monitoring. Int J Antimicrob Agents 2013; 42: 357-60.
7. Scoville BA, Mueller BA. Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis 2013; 61: 490-500.
8. Marchand S, Frat JP, Petitpas F et al. Removal of colistin during intermittent haemodialysis in two critically ill patients. J Antimicrob Chemother 2010; 65: 1836-7.
9. Li J, Rayner CR, Nation RL et al. Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 2005; 49: 4814-5.
10. Karvanen M, Plachouras D, Friberg LE et al. Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother 2013; 57: 668-71.